Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-27

Clinical Trial Update: Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completion update examining whether Schistosoma mansoni infection influences HIV susceptibility and female genital immune responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Toronto | Conditions: Schistosomiasis Mansoni, HIV | Phase 4 | Status: COMPLETED